Hillary S. Sloane

434 total citations
20 papers, 327 citations indexed

About

Hillary S. Sloane is a scholar working on Cancer Research, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Hillary S. Sloane has authored 20 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 8 papers in Molecular Biology and 8 papers in Biomedical Engineering. Recurrent topics in Hillary S. Sloane's work include Cancer Genomics and Diagnostics (11 papers), Biosensors and Analytical Detection (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Hillary S. Sloane is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Biosensors and Analytical Detection (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Hillary S. Sloane collaborates with scholars based in United States, Japan and Spain. Hillary S. Sloane's co-authors include Kimberly M. Kelly, Lindsey T. Brinton, Mark Kester, James P. Landers, Kimberly Kelly, Daniel L. Edelstein, Daniel A. Nelson, Jingyi Li, Frederick S. Jones and Daniel C. Leslie and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Analytical Chemistry.

In The Last Decade

Hillary S. Sloane

19 papers receiving 324 citations

Peers

Countries citing papers authored by Hillary S. Sloane

Since Specialization

Citations

This map shows the geographic impact of Hillary S. Sloane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hillary S. Sloane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hillary S. Sloane more than expected).

Fields of papers citing papers by Hillary S. Sloane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hillary S. Sloane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hillary S. Sloane. The network helps show where Hillary S. Sloane may publish in the future.

Co-authorship network of co-authors of Hillary S. Sloane

This figure shows the co-authorship network connecting the top 25 collaborators of Hillary S. Sloane. A scholar is included among the top collaborators of Hillary S. Sloane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hillary S. Sloane. Hillary S. Sloane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans 2024 ·JAMA Health Forum ·Yonghong Li, (unknown), Hillary S. Sloane, Daniel L. Edelstein, Jeanne Tie, Peter Gibbs, Afsaneh Barzi	12
2	Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC) 2023 ·Oral Oncology ·Panagiota Economopoulou, Aris Spathis, Ioannis Kotsantis, Eirini Maratou, Μaria Anastasiou, Myrto Moutafi, (unknown), (unknown), (unknown), Daniel L. Edelstein, Hillary S. Sloane, Johannes Fredebohm, Frederick S. Jones, Anastasios Kyriazoglou, Niki Gavrielatou, Periklis Foukas, Ioannis G. Panayiotides, Amanda Psyrri	11
3	Abstract P5-05-04: Estrogen receptor 1 (ESR1) mutations in circulating tumor DNA (ctDNA) from patients with ER+/HER2- metastatic breast cancer (mBC) treated with lasofoxifene or fulvestrant in the ELAINE 1 study 2023 ·Cancer Research ·Matthew P. Goetz, Einav Nili Gal‐Yam, Daniel G. Stover, Sarah Sammons, Stephanie L. Graff, Grace Wang, Massimo Cristofanilli, (unknown), Hillary S. Sloane, (unknown), Paul V. Plourde, David Portman	0
4	Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response 2022 ·Therapeutic Advances in Medical Oncology ·(unknown), Esther Zamora, Santiago Escrivá-de-Romaní, (unknown), José Jiménez, Cristina Saura, Hillary S. Sloane, (unknown), Johannes Fredebohm, (unknown), Graham Speight, Frederick S. Jones, Santiago Ramón y Cajal, Martín Espinosa-Bravo, Vicente Peg	7
5	Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment 2022 ·BMC Cancer ·Ari J. Rosenberg, Evgeny Izumchenko, Alexander T. Pearson, Zhen Gooi, Elizabeth A. Blair, Theodore Karrison, Aditya Juloori, Daniel Thomas Ginat, Nicole A. Cipriani, Mark W. Lingen, Hillary S. Sloane, Daniel L. Edelstein, Kirsten A. Keyser, Johannes Fredebohm, Frank Holtrup, Frederick S. Jones, Daniel J. Haraf, Nishant Agrawal, Everett E. Vokes	9
6	Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas 2022 ·Cancers ·(unknown), Vanesa García‐Barberán, (unknown), (unknown), Hillary S. Sloane, Frederick S. Jones, Pedro Pérez‐Segura	8
7	164P Rapid liquid biopsy genotyping in NSCLC patients 2021 ·Journal of Thoracic Oncology ·(unknown), Hillary S. Sloane, Daniel L. Edelstein, Frederick S. Jones, (unknown), Sam Wu, Jenna Los, Frank Holtrup, Hannah Quinn, David Feller‐Kopman	1
8	Ultra-sensitive detection and quantification of HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial. 2021 ·Journal of Clinical Oncology ·Hillary S. Sloane, Evgeny Izumchenko, Austin K. Mattox, Rifat Hasina, (unknown), Frederick S. Jones, Hannah Quinn, Kirsten A. Keyser, Johannes Fredebohm, Frank Holtrup, Alexander T. Pearson, Everett E. Vokes, Tanguy Y. Seiwert, Daniel L. Edelstein, Ari J. Rosenberg, Nishant Agrawal	6
9	Abstract LB053: Clinical evaluation of NGS-based liquid biopsy genotyping in non-small cell lung cancer (NSCLC) patients 2021 ·Cancer Research ·Hillary S. Sloane, (unknown), Daniel L. Edelstein, Frederick S. Jones, (unknown), Sam Wu, Jenna Los, (unknown), Johannes Fredebohm, (unknown), (unknown), Frank Holtrup, Hannah Quinn, David Feller‐Kopman	1
10	Ultrasensitive Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML) Using a Targeted Next Generation Sequencing (NGS) Panel 2020 ·Blood ·(unknown), Hillary S. Sloane, Johannes Fredebohm, (unknown)	1
11	Abstract 2285: Comparison of the nCyte Dx and CellSearch systems for CTC enumeration 2019 ·Cancer Research ·(unknown), (unknown), (unknown), John N. Kearney, (unknown), Hillary S. Sloane	1
12	Hybridization-Induced Aggregation Technology for Practical Clinical Testing 2016 ·Journal of Molecular Diagnostics ·Hillary S. Sloane, James P. Landers, Kimberly M. Kelly	2
13	Warfarin genotyping with hybridization-induced aggregation on a poly(ethylene terephthalate) microdevice 2016 ·The Analyst ·Hillary S. Sloane, (unknown), (unknown), Delphine Le Roux, (unknown), James P. Landers	4
14	A novel, integrated forensic microdevice on a rotation‐driven platform: Buccal swab to STR product in less than 2 h 2016 ·Electrophoresis ·(unknown), (unknown), (unknown), (unknown), Hillary S. Sloane, (unknown), (unknown), (unknown), James P. Landers, Tracey Dawson Cruz	7
15	Investigation of the DNA target design parameters for effective hybridization-induced aggregation of particles for the sequence-specific detection of DNA 2015 ·The Analyst ·(unknown), Hillary S. Sloane, (unknown), Daniel C. Leslie, James P. Landers	8
16	Reversible phospholipid nanogels for deoxyribonucleic acid fragment size determinations up to 1500 base pairs and integrated sample stacking 2015 ·Analytica Chimica Acta ·(unknown), (unknown), Hillary S. Sloane, Sławomir Łukomski, James P. Landers, Lisa Holland	10
17	A simple integrated microfluidic device for the multiplexed fluorescence-free detection of Salmonella enterica 2015 ·The Analyst ·(unknown), Hillary S. Sloane, Eric R. Houpt, (unknown), (unknown), Jingyi Li, Daniel A. Nelson, James P. Landers	6
18	Rapid KRAS Mutation Detection via Hybridization-Induced Aggregation of Microbeads 2015 ·Analytical Chemistry ·Hillary S. Sloane, Kimberly Kelly, James P. Landers	20
19	Dual-force aggregation of magnetic particles enhances label-free quantification of DNA at the sub-single cell level 2014 ·Analytica Chimica Acta ·Daniel A. Nelson, (unknown), Hillary S. Sloane, Jingyi Li, James P. Landers	13
20	Formation and role of exosomes in cancer 2014 ·Cellular and Molecular Life Sciences ·Lindsey T. Brinton, Hillary S. Sloane, Mark Kester, Kimberly M. Kelly	200

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact